References
- Thiagarajan RR, Barbaro RP, Rycus PT, et al. Extracorporeal Life Support Organisation Registry International Report 2016. ASAIO J. 2017;63:60‐7.
- Millar JE, Fanning JP, McDonald CI, McAuley DF, Fraser JF. The inflammatory response to extracorporeal membrane oxygenation (ECMO): a review of the pathophysiology. Crit Care. 2016;20:387.
- Wang S, Krawiec C, Patel S, et al. Laboratory evaluation of hemolysis and systemic inflammatory response in neonatal non-pulsatile and pulsatile extracorporeal life support systems. Artif Organs. 2015;39:774-81.
- Rungatscher A, Tessari M, Stranieri C, et al. Oxygenator is the main responsible for leukocyte activation in an experimental model of extracorporeal circulation: a cautionary tale. Mediators Inflamm. 2015;2015:484979.
- McILwain RB, Timpa JG, Kurundkar AR, et al. Plasma concentrations of inflammatory cytokines rise rapidly during ECMO-related SIRS due to the release of preformed stores in the intestine. Lab Invest. 2010;90:128-39.
- Mildner RJ, Taub N, Vyas JR, et al. Cytokine imbalance in infants receiving extracorporeal membrane oxygenation for respiratory failure. Biol Neonate. 2005;88:321-7.
- Graulich J, Sonntag J, Marcinkowski M, et al. Complement activation by in vivo neonatal and in vitro extracorporeal membrane oxygenation. Mediators Inflamm. 2002;11:69-73.
- Doyle AJ, Hunt BJ. Current understanding of how extracorporeal membrane oxygenators activate haemostasis and other blood components. Front Med (Lausanne). 2018;5:352..
- Sniderman J, Monagle P, Annich GM, MacLaren G. Hematologic concerns in extracorporeal membrane oxygenation. Res Pract Thromb Haemost. 2020;4:455-468.
- Graulich J, Walzog B, Marcinkowski M, et al. Leukocyte and endothelial activation in a laboratory model of extracorporeal membrane oxygenation (ECMO) Pediatr Res. 2000;48:679-84.
- Singer M, Deutschman CS, Seymour CW, et al. The Third International Consensus Definitions for Sepsis and Septic Shock (Sepsis-3). JAMA. 2016;315:801‐10.
- Beck L, Burg MC, Heindel W, Schülke C. Extracorporeal Membrane Oxygenation in Adults - Variants, Complications during Therapy, and the Role of Radiological Imaging. Rofo. 2017;189:119‐27.
- Sidebotham D, McGeorge A, McGuinness S, Edwards M, Willcox T, Beca J. Extracorporeal membrane oxygenation for treating severe cardiac and respiratory failure in adults: part 2-technical considerations. J Cardiothorac Vasc Anesth. 2010;24:164‐72.
- Moldoveanu B, Otmishi P, Jani P, et al. Inflammatory mechanisms in the lung. J Inflamm Res 2009;2:1‐11.
- Hayashi T, Beck L, Rossetto C, et al. Inhibition of experimental asthma by indoleamine 2,3-dioxygenase. J Clin Invest 2004;114:270-9
- Raychaudhuri B, Fisher CJ, Farver CF, et al. Interleukin 10 (IL-10)-mediated inhibition of inflammatory cytokine production by human alveolar macrophages. Cytokine. 2000;12:1348-55.
- Pittet JF, Griffiths MJ, Geiser T, et al. TGF-beta is a critical mediator of acute lung injury. J Clin Invest 2001;107:1537-44.